Oxford BioDynamics Plc (LON:OBD – Get Free Report) was up 10.3% during mid-day trading on Tuesday . The company traded as high as GBX 1.50 ($0.02) and last traded at GBX 1.50 ($0.02). Approximately 2,264,701 shares changed hands during trading, an increase of 25% from the average daily volume of 1,811,900 shares. The stock had previously closed at GBX 1.36 ($0.02).
Oxford BioDynamics Stock Performance
The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80. The company has a market capitalization of £4.68 million, a PE ratio of -22.67 and a beta of 0.42. The firm’s fifty day simple moving average is GBX 1.85 and its 200 day simple moving average is GBX 5.14.
Insider Transactions at Oxford BioDynamics
In related news, insider David Holbrook bought 49,653 shares of the business’s stock in a transaction dated Monday, October 28th. The stock was acquired at an average price of GBX 1 ($0.01) per share, with a total value of £496.53 ($628.44). Corporate insiders own 16.78% of the company’s stock.
About Oxford BioDynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Featured Stories
- Five stocks we like better than Oxford BioDynamics
- Differences Between Momentum Investing and Long Term Investing
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
- Buy P&G Now, Before It Sets A New All-Time High
- 3 S&P 500 Stocks With Sky High Risk-Adjusted Returns
- What Investors Need to Know to Beat the Market
- Trending Stocks: How to Spot, Trade, and Profit Safely
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.